- Home
- PBH
as 07-08-2024 4:00pm EST
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | TARRYTOWN |
| Market Cap: | 3.2B | IPO Year: | 2005 |
| Target Price: | $86.50 | AVG Volume (30 days): | 264.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $56.34 - $75.31 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,125,357,000 | Revenue Growth: | -0.21% |
| Revenue Growth (this year): | 1.3% | Revenue Growth (next year): | 2.46% |
Stock Insider Trading Activity of Prestige Consumer Healthcare Inc. (PBH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Mar 1 '24 | Sell | $70.43 | 62 | $4,366.66 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Mar 1 '24 | Sell | $70.41 | 110 | $7,745.10 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 27 '24 | Sell | $70.00 | 1 | $70.00 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 27 '24 | Sell | $70.19 | 246 | $17,266.74 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 27 '24 | Sell | $70.36 | 416 | $29,269.76 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 23 '24 | Sell | $70.00 | 12 | $840.00 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 23 '24 | Sell | $70.00 | 11 | $770.00 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 23 '24 | Sell | $70.43 | 5,132 | $361,446.76 | 15,934 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 23 '24 | Sell | $70.44 | 4,545 | $320,149.80 | 15,934 | SEC Form 4 |
| Mekhail Adel | PBH | EVP, Marketing & Sales | Feb 15 '24 | Sell | $69.21 | 4,000 | $276,840.00 | 18,681 | SEC Form 4 |
| Mekhail Adel | PBH | EVP, Marketing & Sales | Feb 15 '24 | Sell | $69.08 | 11,549 | $797,804.92 | 18,681 | SEC Form 4 |
| Sacco Christine | PBH | Chief Financial Officer | Feb 14 '24 | Sell | $68.08 | 5,231 | $356,126.48 | 24,738 | SEC Form 4 |
| Sacco Christine | PBH | Chief Financial Officer | Feb 14 '24 | Sell | $68.41 | 24,788 | $1,695,747.08 | 21,738 | SEC Form 4 |
| P'Pool William | PBH | See remarks | Feb 14 '24 | Sell | $68.02 | 12,336 | $839,094.72 | 24,917 | SEC Form 4 |
| P'Pool William | PBH | See remarks | Feb 14 '24 | Sell | $67.79 | 13,683 | $927,570.57 | 24,917 | SEC Form 4 |
| Fritz Mary Beth | PBH | SVP Quality & Regulatory | Feb 8 '24 | Sell | $69.00 | 5,336 | $368,184.00 | 15,934 | SEC Form 4 |
Latest Prestige Consumer Healthcare Inc. News
PBH Breaking Stock News: Dive into PBH Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Simply Wall St.
7 days ago
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Stock Is Going Strong: Is the Market Following Fundamentals?
GlobeNewswire
a month ago
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
GuruFocus.com
2 months ago
Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...
Morningstar Research
2 months ago
Analyst Report: Prestige Consumer Healthcare Inc.
GlobeNewswire
2 months ago
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
Zacks
2 months ago
Will Cresco Labs Inc. (CRLBF) Report Negative Earnings Next Week? What You Should Know
Morningstar Research
2 months ago
Analyst Report: Prestige Consumer Healthcare Inc.
Share on Social Networks:
Disclaimer
The information presented on this page, "PBH Prestige Consumer Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.